PMA device
ASSURE Wearable Cardioverter Defibrillator (WCD) System
Kestra Medical Technologies, Inc. · Wearable Automated External Defibrillator (MVK, Class III) · First FDA decision Jul 27, 2021, newest Mar 6, 2026Ventricular arrhythmia and sudden cardiac arrest
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
39
Naming "ASSURE"
MAUDE reports
1,636
Brand "ASSURE", since 2015
PubMed studies
15,772
Mentioning "ASSURE"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing ASSURE Wearable Cardioverter Defibrillator (WCD) System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- ASSURE Wearable Cardioverter Defibrillator (WCD) SystemPMA supplement
P200037-S018 · Decided Mar 6, 2026 · 179 days after receipt · Normal 180 Day Track
Device type: Wearable automated external defibrillator (MVK) · Cardiology
- Assure Wearable Cardioverter Defibrillator (WCD) systemPMA supplement
P200037-S004 · Decided Oct 25, 2022 · 145 days after receipt · Normal 180 Day Track
Device type: Wearable automated external defibrillator (MVK) · Cardiology
P200037 · Decided Jul 27, 2021 · 348 days after receipt
Device type: Wearable automated external defibrillator (MVK) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web BasedLocal determinationIn effectL34087CGS Administrators, LLCUpdated Aug 28, 2026
- Automatic External DefibrillatorsLocal determinationIn effectL33690CGS Administrators, LLCUpdated Feb 13, 2020
Clinical trials
Device studies on ClinicalTrials.gov that name "ASSURE", any status and sponsor, newest update first.
- Safety and Effectiveness Assessment of AneuFix Injectable Polymer Sac Filling to Assure Long-term Durability of EVAR.Pivotal-lookingNot yet recruiting
TripleMed B.V.Not on our public-company list
NCT07928505 · 150 participants (planned) · Start Jan 15, 2027 · Primary completion Dec 31, 2029
Device: AneuFix Injectable Polymer · For: Endoleak After Endovascular Aneurysm Repair; Aortic Aneurysm Abdominal
Sites: Amsterdam, Netherlands
University of Texas Southwestern Medical CenterAcademic, hospital or other
NCT06866353 · 20 participants · Start May 22, 2025 · Primary completion Sep 6, 2025
Device: Walking with different walkers · For: Ataxia - Other
Sites: Dallas, Texas
- An Enhanced Home-Based Telemedicine Program Using Remote Examination Devices for Children With Medical ComplexityPivotal-lookingCompleted
The University of Texas Health Science Center, HoustonAcademic, hospital or other
NCT05408143 · 254 participants · Start Jul 12, 2022 · Primary completion Aug 26, 2024
Device: Enhanced telemedicine (ETM) · For: Chronic Diseases in Children
Sites: Houston, Texas
36 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "ASSURE", and for the whole product code for context.
This brand
1,636 reports: 1,506 malfunction, 71 injury, 58 death
Whole product code MVK
133,849 reports: 93,827 malfunction, 36,492 injury, 3,526 death
Newest reports for this brand
- ASSURE WEARABLE CARDIOVERTER DEFIBRILLATORMalfunction
KESTRA MEDICAL TECHNOLOGIES, INC.
3015185344-2026-00578 · Received Oct 27, 2026 · Event dated Oct 23, 2026
Device type: Wearable Automated External Defibrillator (MVK)
Device problem as coded: Electrical /Electronic Property Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- ASSURE WEARABLE CARDIOVERTER DEFIBRILLATORMalfunction
KESTRA MEDICAL TECHNOLOGIES, INC.
3015185344-2026-00577 · Received Oct 27, 2026 · Event dated Oct 22, 2026
Device type: Wearable Automated External Defibrillator (MVK)
Device problem as coded: Electrical /Electronic Property Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- ASSURE WEARABLE CARDIOVERTER DEFIBRILLATORMalfunction
KESTRA MEDICAL TECHNOLOGIES, INC.
3015185344-2026-00575 · Received Oct 27, 2026 · Event dated Oct 21, 2026
Device type: Wearable Automated External Defibrillator (MVK)
Device problem as coded: Electrical /Electronic Property Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "ASSURE"[tiab]. The summary above synthesizes these.
- Auricular reconstruction.
Cook TA, Miller PJ · Facial Plast Surg · 1995
- Ion Channels and Neurological Disease.
Musio C · Life (Basel) · 2024Editorial
- The aging anesthesiologist.
Katz JD · Curr Opin Anaesthesiol · 2016Review
- Look back to assure a better future.
Porter S, Carneiro Leão J, Cohen Goldemberg D, et al. · Br Dent J · 2020Editorial
- Animal health assurance.
Donovan J, Brown P · Curr Protoc Neurosci · 2002
- On Hymenoplasty.
DelVecchio Good MJ · J Clin Ethics · 2015Comment
- Editorial: Pharmacometrics-tools to assure optimal medicine use in low- and middle-income countries.
Abulfathi AA, Chaba LA, Svensson EM, et al. · Front Pharmacol · 2022Editorial
- Pseudocyesis.
Zuber T, Kelly J · Am Fam Physician · 1984Case Reports
- [Hemicorporectomy anesthesia: case report].
Rego CO, Costa RBF, Carmona BM · Braz J Anesthesiol · 2020Case Reports
- Microbiological Test Data-Assuring Data Integrity.
Tidswell EC, Sandle T · PDA J Pharm Sci Technol · 2018Review
- Long-Term Efficacy and Safety of Selective PPARδ Agonist Seladelpar in Primary Biliary Cholangitis: ASSURE Interim Study Results.
Levy C, Trivedi PJ, Kowdley KV, et al. · Am J Gastroenterol · 2025
Other devices of this type
Also filed under product code MVK.
- LifeVest Wearable DefibrillatorZoll Manufacturing Corporation · PMA 2023
- Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)Element Science, Inc. · PMA 2025
- Wearable Cardioverter Defibrillator (Wcd) 2000 LifevestZoll Manufacturing Corporation · PMA 2018
- Lifevest Wcd 3000 SystemZoll Manufacturing Corporation · PMA 2002
- Hospital Wearable Defibrillator (Hwd 1000)Zoll Manufacturing Corporation · PMA 2017
- Lifevest Waerable DefibrillatorZoll Manufacturing Corporation · PMA 2012
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.